93 782 (Tamoxifen 20 mg)
This pill with imprint "93 782" is White, Round and has been identified as Tamoxifen citrate 20 mg. It is manufactured by Teva Pharmaceuticals USA.
Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer, metastatic; breast cancer, male; breast cancer; mccune-albright syndrome (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 93 782
- 20 mg
- 9.00 mm
- Prescription only
- Drug Class:
Selective estrogen receptor modulators
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|54868-4287||Physicians Total Care Inc (repackager)|
|54569-5857||A-S Medication Solutions, LLC (repackager)|
More about tamoxifen
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 50 Reviews – Add your own review/rating
- Drug class: hormones/antineoplastics
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.